Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome

American Journal of Ophthalmology

Volumn 147, Issue 6, 2009, Pages

  Williams, George A ^a   Haller, Julia A ^b   Kuppermann, Baruch D ^c   Blumenkranz, Mark S ^d   Weinberg, David V ^e   Chou, Connie ^f   Whitcup, Scott M ^f  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; DRUG DELIVERY SYSTEM; ENDOPHTHALMITIS; EYE DISEASE; EYE PAIN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; IRVINE GASS SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA MACULOPATHY; UVEITIS; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 67349125916     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.12.033     Document Type: Article

References (24)

1. Gritz D.C., and Wong I.G. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology 111 (2004) 491-500
2. Durrani O.M., Tehrani N.N., Marr J.E., et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88 (2004) 1159-1162
3. Rossetti L., and Autelitano A. Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 11 (2000) 65-72
4. Leopold I.H. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears M., and Tarkkanen A. (Eds). Surgical pharmacology of the eye (1985), Raven Press, New York, New York 83-133
5. Nauck M., Karakiulakis G., Perruchoud A., et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Euro J Pharmacol 341 (1998) 309-315
6. Tennant J.L. Cystoid maculopathy: 125 prostaglandins in ophthalmology. In: Emery J.M. (Ed). Current concepts in cataract surgery: selected proceedings of the fifth biennial cataract surgical congress, Section 3 (1978), CV Mosby, St Louis, Missouri 360-362
7. Antonetti D.A., Barber A.J., Khin S., et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47 (1998) 1953-1959
8. Antonetti D.A., Wolpert E.B., D Maio L., et al. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80 (2002) 667-677
9. Jonas J.B., Kreissig I., Sofker A., and Degenring R.F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121 (2003) 57-61
10. Sutter F.K.P., Simpson J.M., and Gillies M.C. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: 3-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 (2004) 2044-2049
11. Young S., Larkin G., Branley M., and Lightmann S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 29 (2001) 2-6
12. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
13. Hayashi K., and Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 139 (2005) 972-982
14. Jaffe G.J., Martin D., Callanan D., et al., Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: 34-week results of a multicenter randomized clinical study. Ophthalmology 113 (2006) 1020-1027
15. Kuppermann B.D., Blumenkranz M.S., Haller J.A., et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 125 (2007) 309-317
16. Fung W.E. Vitrectomy for chronic aphakic cystoid macular edema: results of a national, collaborative, prospective, randomized investigation. Ophthalmology 92 (1985) 1102-1111
17. Whitcup S.M., Csaky K.G., Podgor M.J., et al. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology 103 (1996) 1054-1062
18. Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics: ETDRS Report No. 7. Ophthalmology 98 (1991) 741-756
19. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4. Am J Ophthalmol 131 (2001) 167-175
20. Butcher J., Austin M., McGalliard J., and Bourke R. Bilateral cataracts and glaucoma induced by long-term use of steroid eye drops. Br Med J 309 (1994) 43
21. Armaly M. Statistical attributes of the steroid hypertensive response in the clinically normal eye. Invest Ophthalmol Vis Sci 4 (1965) 187-197
22. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci 4 (1965) 198-205
23. Van Kooij B., Rothova A., and de Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm 14 (2006) 73-85
24. Goldstein D.A., Godfrey D.G., Hall A., et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol 125 (2007) 1478-1485